FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to glucagon-like peptide 1 secretion stimulation and to foodstuffs and beverages stimulating glucagon-like peptide 1 secretion and containing k-casein as the active component. declaration is made for a medicinal glucagon-like peptide-1 secretagogue containing k-casein as the active component.
EFFECT: invention ensures glucagon-like peptide 1 secretion stimulation and postprandial hyperglycemia inhibition.
2 cl, 2 ex, 4 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| GLUCAGON-LIKE PEPTIDE-1 ANALOGUES AND USING THEM | 2011 |
|
RU2531590C2 |
| LONG-ACTING DOUBLE AGONIST OF GLUCAGON-LIKE PEPTIDE-1 AND GLUCAGON RECEPTORS | 2021 |
|
RU2799327C1 |
| MEDICINAL AGENT AND FOODSTUFF OR BEVERAGE FOR DECREASING HYPERGLYCEMIA | 2005 |
|
RU2315601C1 |
| METHOD AND PHARMACEUTICAL COMPOSITIONS FOR TREATING POSTPRANDIAL HYPERGLYCEMIA ACCOMPANYING TYPE II DIABETES MELLITUS BY ADMINISTERING THROUGH ORAL MUCOSA | 2010 |
|
RU2543635C2 |
| COMBINATION FOR REGENERATIVE THERAPY OF TYPE 1 DIABETES MELLITUS | 2018 |
|
RU2694527C1 |
| METHOD FOR PREVENTING GLP-1 SIDE EFFECTS | 2008 |
|
RU2474415C2 |
| HUMAN OXYNTOMODULIN, ITS APPLICATION, MEDICATION BASED THEREON AND METHOD OF APPLYING MEDICATION FOR TREATMENT AND PREVENTION OF HYPERGLYCEMIA | 2009 |
|
RU2524204C2 |
| GLYCOSIDE DERIVATIVE, METHOD FOR ITS PREPARING, COMPOSITION, AGENT FOR CORRECTION OF HYPERGLYCEMIA, MEDICINAL AGENT, FOODSTUFFS, METHOD FOR CORRECTION OF HYPERGLYCEMIA | 2005 |
|
RU2315770C1 |
| PHARMACEUTICAL COMPOSITIONS, CONTAINING GLUCAGON-LIKE PEPTIDE 1 (GLP-1) | 2007 |
|
RU2542500C2 |
| PEPTIDES OF MARINE ORIGIN AND FISH NUCLEOTIDES, COMPOSITIONS AND USE THEREOF FOR REDUCING BLOOD GLUCOSE | 2015 |
|
RU2713935C1 |
